The pilot scheme, AI Airlock, is designed to help test and improve the rules for AI-powered medical devices to ensure they reach patients quickly ...

Second-hand smoke contains over 7,000 chemicals that can increase the risk of your kid developing allergies, repeated coughs ...

The Science of Breathing Breathing is vital for survival because it gives your body oxygen and expels carbon dioxide. However ...

Leading New Zealand health expert Lutz Beckert wants a new Australian Government standard of care for chronic obstructive ...

Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year ...

Vitamin D receptor has antiproliferative effects in pulmonary arterial hypertension, but receptor expression is downregulated ...

Workers who build engineered stone countertops often present with atypical and advanced features of silicosis, which may be ...

Several adverse health outcomes are associated with AD, such as atopic and allergic conditions, immune mediated conditions, and more.

Queen reveals she is recovering from pneumonia – what we know so far - Camilla temporarily stepped back from some duties in ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.

On December 2, 2024, Apogee Therapeutics, a clinical-stage biotechnology company, released a press release detailing the significant advancements made in its novel biologic programs for Inflammatory ...